Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Atherosclerosis
100%
Cardiovascular System
67%
Cardiovascular Disease
65%
Diseases
65%
Coronary Artery Disease
57%
Atherosclerotic Plaque
53%
Myocardial Infarction
52%
Magnetic Resonance Imaging
51%
Platelet
49%
Thrombosis
45%
Lipid
44%
Ischemic Heart Disease
40%
Acute Coronary Syndrome
37%
Cardiac Magnetic Resonance Imaging
33%
Hypertension
29%
Congestive Heart Failure
28%
Cardiovascular Risk
27%
Thrombus
26%
Unstable Angina Pectoris
22%
Polypill
22%
Macrophage
22%
Coronary Artery Bypass Graft
21%
Pulmonary Hypertension
21%
Inflammation
20%
Coronary Artery
19%
Prevalence
19%
Pathogenesis
19%
Blood Clotting
19%
Percutaneous Coronary Intervention
19%
Acetylsalicylic Acid
18%
Health Promotion
17%
Diabetes Mellitus
17%
Patient with Diabetes
17%
Revascularization
16%
Apoplexy
16%
Angioplasty
16%
Health Care Cost
16%
Stenosis
16%
Acute Heart Infarction
16%
Secondary Prevention
16%
Clinical Trial
15%
Diabetes
15%
Thromboembolism
15%
Myocardial Disease
14%
Restenosis
13%
Infarction
13%
Rhythm
13%
Transluminal Coronary Angioplasty
13%
Computer Assisted Tomography
13%
Valvular Heart Disease
12%
Keyphrases
Cardiovascular Disease
46%
Platelets
44%
Atherosclerotic Plaque
44%
Acute Coronary Syndrome
43%
Aspirin
43%
Plaque
40%
Cardiac Magnetic Resonance Imaging (cMRI)
40%
Subclinical Atherosclerosis
39%
Myocardial Infarction
38%
Thrombosis
35%
Stable Angina
30%
Antithrombotic Therapy
26%
Thrombus
26%
Atherosclerotic Lesions
25%
Acute Myocardial Infarction
24%
Platelet Deposition
24%
Risk Factors
24%
Thrombus Formation
23%
Cardiovascular Risk Factors
23%
Plaque Rupture
23%
Coronary Artery Bypass Grafting
22%
Percutaneous Coronary Intervention
22%
Atrial Fibrillation
22%
95% Confidence Interval
21%
Cardiac Magnetic Resonance
21%
Coronary Artery Disease
21%
Inflammation
19%
Heparin
18%
Coronary Disease
18%
Vessel Wall
18%
Platelet Aggregation Inhibitors
17%
High Risk
17%
Atherosclerotic Disease
17%
Macrophages
17%
Angioplasty
17%
Beta-blockers
16%
Atherothrombosis
16%
Polypill
16%
Clinical Trials
16%
Hypertension
15%
Anticoagulation
15%
COVID-19
15%
Dipyridamole
15%
Metoprolol
15%
Secondary Prevention
14%
ST-elevation Myocardial Infarction (STEMI)
14%
Heart Failure
13%
Statins
13%
Pulmonary Hypertension
13%
Hirudin
13%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
52%
Heart Infarction
45%
Diseases
43%
Acetylsalicylic Acid
43%
Thrombosis
40%
Thrombus
36%
Cardiovascular Disease
36%
Anticoagulant Agent
28%
Acute Heart Infarction
28%
Atherosclerotic Plaque
27%
Lipid
24%
Acute Coronary Syndrome
23%
Coronary Artery Disease
23%
Inflammation
23%
Antithrombotic Therapy
21%
Unstable Angina Pectoris
20%
Infarction
20%
Clinical Trial
20%
Congestive Heart Failure
19%
Antithrombocytic Agent
18%
Atrial Fibrillation
17%
Thromboembolism
17%
Pathogenesis
17%
Cerebrovascular Accident
17%
Metoprolol
17%
Heparin
16%
Placebo
16%
Ischemic Heart Disease
16%
Warfarin
15%
Cholesterol
15%
Thromboplastin
14%
Thrombin
14%
Pig
13%
ST Segment Elevation Myocardial Infarction
13%
Diabetes Mellitus
12%
Leporidae
12%
Statin (Protein)
12%
Thrombogenicity
11%
Beta Adrenergic Receptor Blocking Agent
11%
Artery Thrombosis
10%
Dipyridamole
9%
Prevalence
9%
Cardiovascular Risk
9%
Hirudin
8%
Ischemia
8%
Pulmonary Hypertension
8%
Clopidogrel
8%
Antiplatelet
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
High Density Lipoprotein
7%